about
Characterization of the protein corona of gold nanoparticles by an advanced treatment of CE-ICP-MS data.Advances of CE-ICP-MS in speciation analysis related to metalloproteomics of anticancer drugs.Combination of ICP-MS, capillary electrophoresis, and their hyphenation for probing Ru(III) metallodrug-DNA interactions.Characterization of interactions of metal-containing nanoparticles with biomolecules by CE: An update (2012-2016).Cellular processing of gold nanoparticles: CE-ICP-MS evidence for the speciation changes in human cytosol.Use of high-performance liquid chromatography-tandem electrospray ionization mass spectrometry to assess the speciation of a ruthenium(III) anticancer drug in the cytosol of cancer cells.A shotgun metalloproteomic approach enables identification of proteins involved in the speciation of a ruthenium anticancer drug in the cytosol of cancer cells.Molecular mass spectrometry in metallodrug development: a case of mapping transferrin-mediated transformations for a ruthenium(III) anticancer drug.Metallomics for drug development: a further insight into intracellular activation chemistry of a ruthenium(III)-based anticancer drug gained using a multidimensional analytical approach.CE Separation and ICP-MS Detection of Gold Nanoparticles and Their Protein Conjugates.The fate of differently functionalized gold nanorods in human serum: A response from capillary electrophoresis-inductively coupled plasma mass spectrometry.A sensitive and versatile method for characterization of protein-mediated transformations of quantum dots.Speciation of metal-based nanomaterials in human serum characterized by capillary electrophoresis coupled to ICP-MS: a case study of gold nanoparticles.Can neutral analytes be concentrated by transient isotachophoresis in micellar electrokinetic chromatography and how much?The impact of the various chemical and physical factors on the degradation rate of bronopolComparison of detection techniques for capillary electrophoresis analysis of gold nanoparticlesAnalytical methodology for studying cellular uptake, processing and localization of gold nanoparticlesCharacterization of quantum dots in cancer cytosol using ICP-MS-based combined techniquesAn improved protocol for ICP-MS-based assessment of the cellular uptake of metal-based nanoparticlesJoint forces of direct, single particle, CE- and HPLC-inductively coupled plasma mass spectrometry techniques for the examination of gold nanoparticle accumulation, distribution and changes inside human cellsFirst application of CE-ICP-MS for monitoring the formation of cisplatin targeting delivery systems with gold nanocarriers
P50
Q31107515-B69699EC-6487-4773-BE1C-051786DB8955Q38062674-CF02A56D-7022-4145-B7DD-B328A1794E06Q38289334-4F35CE5D-DDF7-4733-9C7D-CA1F972359E1Q39255937-AEF2722D-47A7-4705-AADF-B846ECD795A4Q46260618-82B24734-207D-4C70-B627-0FCA8A63B12BQ46740099-F0A1D4C6-944F-43F7-90FA-76506689BD83Q46750665-131452B9-A235-4DFF-AFF8-7F612CD282CFQ46808159-9D5BEDEB-0510-4A99-8CCE-4998305C16DAQ46970233-10B8A52E-601D-45C1-BC45-95C573101831Q47094483-AC031FCD-720A-4048-A89C-0C079DCA7FBFQ50740985-B92AB871-A937-4C4A-A896-74193A104152Q51404508-79F1D8F6-CA61-4A57-A1BC-D8469A0CAA9AQ53459567-C95064A7-DA6D-4AF6-A75A-669DF53C3C53Q53559321-050687CA-E514-4F44-847D-AA7B0CD60608Q84184613-352A70D9-5F2A-4F27-8137-02D175A4A283Q86944896-D2FE3D89-5634-4C27-B861-CD936D30AC28Q91235363-E1B0D48B-8F85-4D4E-BEA1-9FBA36D0A20EQ92499339-8CF4A29D-BA09-4B2E-986E-70078227FA46Q92721740-B8FC5B72-930B-43EA-A33E-D99CE84CE299Q92891011-3FF6B7BE-F727-489F-AB2E-5B7C70AA46F0Q92903667-5027BCA8-18AB-4127-9981-A4BE32C0F80D
P50
description
researcher ORCID ID = 0000-0001-5631-8163
@en
name
Magdalena Matczuk
@ast
Magdalena Matczuk
@en
Magdalena Matczuk
@es
Magdalena Matczuk
@nl
type
label
Magdalena Matczuk
@ast
Magdalena Matczuk
@en
Magdalena Matczuk
@es
Magdalena Matczuk
@nl
prefLabel
Magdalena Matczuk
@ast
Magdalena Matczuk
@en
Magdalena Matczuk
@es
Magdalena Matczuk
@nl
P1153
55255127200
P21
P31
P496
0000-0001-5631-8163